The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Methallotionein expression and outcome in patients with metastatic breast cancer (MBC).
Jorge Arturo Rios-Perez
No relevant relationships to disclose
Sameem Abedin
No relevant relationships to disclose
Margaret Quinn Rosenzweig
No relevant relationships to disclose
Su Yon Jung
No relevant relationships to disclose
Rohit Bhargava
No relevant relationships to disclose
Adam Brufsky
No relevant relationships to disclose